Not enough post-marketing experience, under-reporting, diagnosis difficulties, and bad follow-upping of exposed patients signify that the total risk and incidence of hypertension related to VEGFR-TKIs are uncertain. This evidence concerns the gene KDR and hypertensive disorder.